Altepred CD45 expression in C77G carriers influences immune function and outcome of hepatitis C infection

Journal of Medical Genetics

Volumn 43, Issue 8, 2006, Pages 678-684

  Dawes, R ^a   Hennig, B ^b   Irving, W ^c   Petrova, S ^a   Boxall, S ^a   Ward, V ^d   Wallace, D ^a   Macallan, D C ^e   Thursz, M ^f   Hill, A ^b   Bodmer, W ^g   Beverley, P C L ^a   Tchilian, Elma Z ^a  

^a EDWARD JENNER INST FOR VACC RES   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^e ST GEORGE S HOSPITAL   (United Kingdom)

^f ST MARY S HOSPITAL   (United Kingdom)

^g UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; PROTEIN KINASE LCK; BIOLOGICAL MARKER;

ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENOTYPE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MEMORY T LYMPHOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; ANIMAL; CYTOLOGY; EXON; FEMALE; GENE EXPRESSION; GENETICS; HETEROZYGOTE; IMMUNOLOGY; LETTER; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; MOUSE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; TRANSGENIC MOUSE;

HEPATITIS C VIRUS; MUS MUSCULUS;

ANIMALS; ANTIGENS, CD45; BIOLOGICAL MARKERS; CARRIER STATE; CELL PROLIFERATION; EXONS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HEPATITIS C; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, TRANSGENIC; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 33747060756     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.2005.040485     Document Type: Article

References (35)

1. Hermiston ML, Xu Z, Weiss A. CD45: a critical regulator of signaling thresholds in immune cells. Annu Rev Immunol 2003;21:107-37.
2. Penninger JM, Irie-Sasaki J, Sasaki T, Oliveira-dos-Santos AJ. CD45: new jobs for an old acquaintance. Nat Immunol 2001;2:389-96.
3. Akbar AN, Terry L, Timms A, Beverley PC, Janossy G. Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J Immunol 1988;140:2171-8.
4. Okumura M, Matthews RJ, Robb B, Litman GW, Bork P, Thomas ML. Comparison of CD45 extracellular domain sequences from divergent vertebrate species suggests the conservation of three fibronectin type III domains. J Immunol 1996;157:1569-75.
5. Kung C, Pingel JT, Heikinheimo M, Klemola T, Varkila K, Yoo LI, Vuopala K, Poyhonen M, Uhari M, Rogers M, Speck SH, Chatila T, Thomas ML. Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. Nat Med 2000;6:343-5.
6. Tchilian EZ, Wallace DL, Wells RS, Flower DR, Morgan G, Beverley PC. A deletion in the gene encoding the CD45 antigen in a patient with SCID. J Immunol 2001;166:1308-13.
7. Jacobsen M, Schweer D, Ziegler A, Gaber R, Schock S, Schwinzer R, Wonigeit K, Lindert RB, Kantarci O, Schaefer-Klein J, Schipper HI, Oertel WH, Heidenreich F, Weinshenker BG, Sommer N, Hemmer B. A point mutation in PTPRC is associated with the development of multiple sclerosis. Nat Genet 2000;26:495-9.
8. Tchilian EZ, Wallace DL, Dawes R, Imami N, Burton C, Gotch F, Beverley PC. A point mutation in CD45 may be associated with HIV-1 infection. AIDS 2001;15:1892-4.
9. Stanton T, Boxall S, Hirai K, Dawes R, Tonks S, Yasui T, Kanaoka Y, Yuldasheva N, Ishiko O, Bodmer W, Beverley PC, Tchilian EZ. A high-frequency polymorphism in exon in of the CD45 tyrosine phosphatase gene (PTPRC) resulting in altered isoform expression. Proc Natl Acad Sci USA 2003;100:5997-6002.
10. Stanton T, Boxall S, Bennett A, Kaleebu P, Watera C, Whitworth J, French N, Dawes R, Hill AV, Bodmer W, Beverley PC, Tchilian EZ. CD45 variant alleles: possibly increased frequency of a novel exon 4 CD45 polymorphism in HIV seropositive Ugandans. Immunogenetics 2004;56:107-10.
11. Boxall S, McCormick J, Beverley P, Strobel S, De Filippi P, Dawes R, Klersy C, Clementi R, De Juli E, Ferster A, Wallace D, Arico M, Danesino C, Tchilian E. Abnormal cell surface antigen expression in individuals with variant CD45 splicing and histiocytosis. Pediatr Res 2004;55:478-84.
12. Boxall S, Stanton T, Hirai K, Ward V, Yasui T, Tahara H, Tamori A, Nishiguchi S, Shiomi S, Ishiko O, Inaba M, Nishizawa Y, Dawes R, Bodmer W, Beverley PC, Tchilian EZ. Disease associations and altered immune function in CD45 138G variant carriers. Hum Mol Genet 2004;13:2377-84.
13. Thude H, Hundrieser J, Wonigeit K, Schwinzer R. A point mutation in the human CD45 gene associated with defective splicing of exon A. Eur J Immunol 1995;25:2101-6.
14. Lynch KW, Weiss A. A CD45 polymorphism associated with multiple sclerosis disrupts an exonic splicing silencer. J Biol Chem 2001;276:24341-7.
15. Barcellas LF, Caillier S, Dragone L, Elder M, Vittinghoff E, Bucher P, Lincoln RR, Pericak-Vance M, Haines JL, Weiss A, Hauser SL, Oksenberq JR. PTPRC (CD45) is not associated with the development of multiple sclerosis in US patients. Nat Genet 2001;29:23-4.
16. Ballerini C, Rosati E, Salvetti M, Ristori G, Cannoni S, Biagioli T, Massacesi L, Sorbi S, Vergelli M. Protein tyrosine phosphatase receptor-type C exon 4 gene mutation distribution in an Italian multiple sclerosis population. Neurosci Lett 2002;328:325-7.
17. Vorechovsky I, Kralovicova J, Tchilian E, Masterman T, Zhang Z, Ferry B, Misbah S, Chapel H, Webster D, Hellgren D, Anvret M, Hillert J, Hammarstrom L, Beverley PC. Does 77C→G in PTPRC modify autoimmune disorders linked to the major histocompatibility locus? Nat Genet 2001;29:22-3.
18. Vogel A, Strassburg CP, Manns MP. 77 C/G mutation in the tyrosine phosphatase CD45 gene and autoimmune hepatitis: evidence for a genetic link. Genes Immun 2003;4:79-81.
19. Schwinzer R, Witte T, Hundrieser J, Ehlers S, Momot T, Hunzelmann N, Krieg T, Schmidt RE, Wonigeit K. Enhanced frequency of a PTPRC (CD45) exon A mutation (77C→G) in systemic sclerosis. Genes Immun 2003;4:168-9.
20. Gomez-Lira M, Liguori M, Magnani C, Bonamini D, Salviati A, Leone M, Andreoli V, Trojano M, Valentino P, Savettieri G, Quattrone A, Pignatti PF, Momigliano-Richiardi P, Giordano M. CD45 and multiple sclerosis: the exon 4 C77G polymorphism (additional studies and meta-analysis) and new markers. J Neuroimmunol 2003;140:216-21.
21. Mohsen AH, Group TH. The epidemiology of hepatitis C in a UK health regional population of 5.12 million. Gut 2001;48:707-13.
22. Hennig BJ, Hellier S, Frodsham AJ, Zhang L, Klenerman P, Knapp S, Wright M, Thomas HC, Thursz M, Hill AV. Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection. Genes Immun 2002;3:359-67.
23. Thursz M, Yallop R, Goldin R, Trepo C, Thomas HC. Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research. Lancet 1999;354:2119-24.
24. Jurinke C, van den Boom D, Cantor CR, Koster H. The use of MassARRAY technology for high throughput genotyping. Adv Biochem Eng Biotechnol 2002;77:57-74.
25. Tchilian EZ, Dawes R, Hyland L, Montoya M, Le Bon A, Borrow P, Hou S, Tough D, Beverley PC. Altered CD45 isoform expression affects lymphocyte function in CD45 Tg mice. Int Immunol 2004;16:1323-32.
26. Hamann D, Kostense S, Wolthers KC, Otto SA, Baars PA, Miedema F, van Lier RA. Evidence that human CD8+CD45RA+CD27 - cells are induced by antigen and evolve through extensive rounds of division. Int Immunol 1999;11:1027-33.
27. Schwinzer R, Schraven B, Kyas U, Meuer SC, Wonigeit K. Phenotypical and biochemical characterisation of a variant CD45R expression pattern in human leucocytes. Eur J Immunol 1992;22:1095-8.
28. Lucas M, Vargas-Cuero AL, Lauer GM, Barnes E, Willberg CB, Semmo N, Walker BD, Phillips R, Klenerman P. Pervasive influence of hepatitis C virus on the phenotype of antiviral CD8+ T cells. J Immunol 2004;172:1744-53.
29. Kuijpers TW, Vossen MT, Gent MR, Davin JC, Roos MT, Wertheim-van Dillen PM, Weel JF, Baars PA, van Lier RA. Frequencies of circulating cytolytic, CD45RA+CD27-, CD8+ T lymphocytes depend on infection with CMV. J Immunol 2003;170:4342-8.
30. Ouyang Q, Wagner WM, Walter S, Muller CA, Wikby A, Aubert G, Klatt T, Stevanovic S, Dodi T, Pawelec G. An age-related increase in the number of CD8+ T cells carrying receptors for an immunodominant Epstein-Barr virus (EBV) epitope is counteracted by a decreased frequency of their antigen-specific responsiveness. Mech Ageing Dev 2003;124:477-85.
31. Khan N, Shariff N, Cobbold M, Bruton R, Ainsworth JA, Sinclair AJ, Nayak L, Moss PA. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 2002;169:1984-92.
32. Ouyang Q, Wagner WM, Wikby A, Walter S, Aubert G, Dodi AI, Travers P, Pawelec G. Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old. J Clin Immunol 2003;23:247-57.
33. Ouyang Q, Wagner WM, Zheng W, Wikby A, Remarque EJ, Pawelec G. Dysfunctional CMV-specific CD8(+) T cells accumulate in the elderly. Exp Gerontol 2004;39:607-13.
34. Do HT, Baars W, Schwinzer R. Functional significance of the 77G→G polymorphism in the human CD45 gene: enhanced T-cell reactivity by variantly expressed CD45RA isoforms. Transplant Proc 2005;37:51-2.
35. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J, Cheng J, Goedert JJ, Vlahov D, Hilgartner M, Cox S, Little AM, Alexander GJ, Cramp ME, O'Brien SJ, Rosenberg WM, Thomas DL, Carrington M. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004;305:872-4.